Oxidized thymosin &bgr;4
US6602519B1 · kind B1 · utility
10Cited by
4References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 23, 2001 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Jan 23, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of oxidized thymosin &bgr;4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response of septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.